MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaad.2023.06.058

Медицинская библиотека · Journal of the American Academy of Dermatology · 2023

Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry.

Jin Joy Q, Cronin Angel, Roberts-Toler Carla, Yeroushalmi Samuel, Hadeler Edward, Spencer Riley K, Elhage Kareem G, Gondo George, Wallace Elizabeth B, Reddy Soumya M, Han George, Kaffenberger Jessica, Davis Mitchell S, Hakimi Marwa, Scher Jose U, Armstrong April W, Bhutani Tina, McLean Robert R, Liao Wilson

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Psoriasis patients with poor therapeutic response to multiple biologic agents are not well-characterized.

OBJECTIVE

To describe the characteristics associated with development of multiple biologic failure (MBF) versus good clinical response (GR) to the first biologic.

METHODS

This prospective cohort analysis evaluated patients in the multicenter CorEvitas Psoriasis Registry who initiated their first biologic between 2015 and 2020 and were followed for ≥24 months. Multivariable logistic regression identified sociodemographic, clinical, and patient-reported outcomes that differed between MBF (discontinued ≥2 biologics of different classes, each used for ≥90 days, due to inadequate efficacy) and GR (continued use of first biologic for ≥2 years) patients.

RESULTS

One thousand thirty-nine patients were analyzed (490 GR [47.2%], 65 MBF [6.3%]). Female sex, shorter psoriasis duration, earlier year of biologic initiation, prior nonbiologic systemic therapy use, history of hyperlipidemia, and Medicaid insurance were significantly associated with MBF, though the latter 2 variables exhibited wider confidence intervals, indicating a lower level of support. The first-to-second biologic sequence most observed with MBF was Tumor necrosis factor-α inhibitor to IL-17 inhibitor use.

LIMITATIONS: Biologic adherence between visits was not evaluated.

CONCLUSION

Approximately 6% of psoriasis patients met MBF criteria. The results identify characteristics associated with MBF that may distinguish patients warranting more frequent follow-up.

Для цитирования: Jin Joy Q, Cronin Angel, Roberts-Toler Carla, Yeroushalmi Samuel, Hadeler Edward, Spencer Riley K, Elhage Kareem G, Gondo George, Wallace Elizabeth B, Reddy Soumya M, Han George, Kaffenberger Jessica, Davis Mitchell S, Hakimi Marwa, Scher Jose U, Armstrong April W, Bhutani Tina, McLean Robert R, Liao Wilson. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry.. Journal of the American Academy of Dermatology. 2023. DOI: 10.1016/j.jaad.2023.06.058.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.